Tilray Brands (TLRY) Convertible Debt (2018 - 2026)
Tilray Brands' (TLRY) quarterly Convertible Debt came in at $79.5 million in Q2 2026, down 7.98% YoY from $86.4 million in Q2 2025, and down 9.9% on a QoQ basis from $88.3 million in Q1 2026.
Tilray Brands (TLRY) Convertible Debt (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Convertible Debt data on file, last reported at $79.5 million in Q2 2026.
- Quarterly Convertible Debt fell 7.98% year-over-year to $79.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $79.5 million (down 7.98% YoY) and the FY2026 annual result came in at $79.5 million, down 7.98% from the prior year.
- Convertible Debt declined to $79.5 million in Q2 2026, from $88.3 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $501.1 million in Q1 2022 to a low of $79.5 million in Q2 2026.
- A 5-year average of $182.8 million and a median of $123.2 million in 2023 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2023 — Convertible Debt sank 72.8% — and 2024, when it increased 9.75%.
- Tracing TLRY's Convertible Debt over 5 years: stood at $223.3 million in 2022, then tumbled by 44.61% to $123.7 million in 2023, then retreated by 0.77% to $122.7 million in 2024, then fell by 29.72% to $86.3 million in 2025, then fell by 7.8% to $79.5 million in 2026.
- The last three Convertible Debt figures came in at $79.5 million (Q2 2026), $88.3 million (Q1 2026), and $86.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 79.53 Mn |
| Feb 28, 2026 | 88.27 Mn |
| Nov 30, 2025 | 86.26 Mn |
| Aug 31, 2025 | 100.00 Mn |
| May 31, 2025 | 86.43 Mn |
| Feb 28, 2025 | 104.07 Mn |
| Nov 30, 2024 | 122.74 Mn |
| Aug 31, 2024 | 132.65 Mn |
| May 31, 2024 | 105.00 Mn |
| Feb 29, 2024 | 126.59 Mn |
| Nov 30, 2023 | 123.69 Mn |
| Aug 31, 2023 | 120.86 Mn |
| May 31, 2023 | 221.04 Mn |
| Feb 28, 2023 | 223.09 Mn |
| Nov 30, 2022 | 223.30 Mn |
| Aug 31, 2022 | 444.28 Mn |
| May 31, 2022 | 401.95 Mn |
| Feb 28, 2022 | 501.08 Mn |
| Nov 30, 2021 | 554.85 Mn |
| Aug 31, 2021 | 611.65 Mn |